Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US Eroxon Launch In October Will Mark Haleon’s First Foray Into Sexual Health

Sep 04 2024

• By David Ridley

• Source: Shutterstock

Related Content

Futura All Set For US FDA De Novo Application For Eroxon OTC ED Treatment

Oct 04 2022

Delay For Sanofi’s OTC Cialis Study In US Could Be Sign of Hurdles Holding Back Other Switches

May 31 2022

Sanofi Feeling Positive On Cialis Switch Progression As Q2 Sales Rise

Jul 29 2022

Haleon ‘Tight Lipped’ On US Eroxon Roll Out, But Analysts Say 2024 Launch Possible

May 14 2024

‘Meaningful Revenues’ In 2023 Mark Strategic Milestone As Futura Looks To Future

Apr 17 2024

Futura’s Eroxon OTC Erectile Dysfunction Gel Gets UK Launch

Apr 20 2023

Female Sexual Dysfunction, China, Next On The Agenda For Eroxon Creator Futura

Nov 07 2023

ED Indication Reaches US OTC Market With FDA Approval Of UK Firm Futura’s Eroxon Gel

Jun 20 2023

Haleon Enters US OTC Erectile Dysfunction Race With Futura Deal

Jul 19 2023

‘A Phenomenon’ – Futura’s Eroxon ED Gel Gets Off To Flying Start In The UK

Jul 05 2023

UK Cialis Rx-To-OTC Switch World-First For Sanofi, H2 2023 Launch Planned

Mar 14 2023

Related Companies

Haleon plc

Futura Medical plc

Additional Topics

US States Ad Campaigns Advertising, Marketing & Sales Companies Consumer Deals FDA Innovation OTC Devices OTC Drugs StartUps and SMEs

More from Marketing & Advertising

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window